Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

2
0
NAS:ALNY (USA)   Ordinary Shares
$ 265.87 -4.08 (-1.51%) 03:51 PM EST
At Loss
P/B:
1,063.48
Market Cap:
$ 34.29B
Enterprise V:
$ 33.34B
Volume:
653.15K
Avg Vol (2M):
726.74K
Trade In:
Volume:
653.15K
At Loss
Avg Vol (2M):
726.74K
PB Ratio:
1,063.48

ALNY Stock Institutional Ownership and Insider Ownership - Alnylam Pharmaceuticals Inc

128.98
(Mil)
Shares Outstanding
92.99%
116.24 (Mil)
Institutional Ownership
0.41%
0.53 (Mil)
Insider Ownership 1
86.97%
112.1794 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Alnylam Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Alnylam Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders